Ma Ying Long's subsidiary has received a drug registration certificate for Bromfenac Sodium Eye Drops from China's National Medical Products Administration. This medication is intended for the symptomatic treatment of inflammatory conditions affecting the outer and anterior parts of the eye, such as conjunctivitis and scleritis. In separate news, Korea Post is increasing its investment in high-yield assets like AI data centers and European real estate to offset losses in its traditional postal business. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON The cluster contains unrelated news items about a drug registration and investment strategies, lacking a cohesive central theme or significant event.